BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22472563)

  • 1. Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study.
    Brougham MF; Crofton PM; Johnson EJ; Evans N; Anderson RA; Wallace WH
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2059-67. PubMed ID: 22472563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ; Whelan K; McCormick K; McLaren JF
    Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripubertal changes in circulating antimüllerian hormone levels in girls.
    Lashen H; Dunger DB; Ness A; Ong KK
    Fertil Steril; 2013 Jun; 99(7):2071-5. PubMed ID: 23419927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
    Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
    Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
    Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
    Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cancer therapies on ovarian reserve.
    Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?
    Crofton PM; Thomson AB; Evans AE; Groome NP; Bath LE; Kelnar CJ; Wallace WH
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):296-301. PubMed ID: 12608934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
    Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
    Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age.
    Rosendahl M; Andersen CY; la Cour Freiesleben N; Juul A; Løssl K; Andersen AN
    Fertil Steril; 2010 Jun; 94(1):156-66. PubMed ID: 19342041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
    Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
    Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer.
    Anderson RA; Cameron DA
    J Clin Endocrinol Metab; 2011 May; 96(5):1336-43. PubMed ID: 21325458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients.
    Hagen CP; Aksglaede L; Sørensen K; Main KM; Boas M; Cleemann L; Holm K; Gravholt CH; Andersson AM; Pedersen AT; Petersen JH; Linneberg A; Kjaergaard S; Juul A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):5003-10. PubMed ID: 20719830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study.
    Siemensma EP; van Alfen-van der Velden AA; Otten BJ; Laven JS; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1766-73. PubMed ID: 22723315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study.
    Hagen CP; Aksglaede L; Sørensen K; Mouritsen A; Andersson AM; Petersen JH; Main KM; Juul A
    Hum Reprod; 2012 Mar; 27(3):861-6. PubMed ID: 22215627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
    Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood.
    Laporte S; Couto-Silva AC; Trabado S; Lemaire P; Brailly-Tabard S; Espérou H; Michon J; Baruchel A; Fischer A; Trivin C; Brauner R
    BMC Pediatr; 2011 Feb; 11():20. PubMed ID: 21352536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
    Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.
    Janse F; Donnez J; Anckaert E; de Jong FH; Fauser BC; Dolmans MM
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1136-44. PubMed ID: 21289248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone in children: a ten-year prospective longitudinal study (EarlyBird 39).
    Jeffery A; Streeter AJ; Hosking J; Wilkin TJ; Nelson SM
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1153-62. PubMed ID: 26030784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.